Pays: Malaisie
Langue: anglais
Source: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
BUDESONIDE
Nano Medic Care Sdn. Bhd.
BUDESONIDE
200units Units
Synmosa Biopharma Corporation
Page 1 of 2 pages _Consumer Medication Information Leaflet (RiMUP) _ AVACORT HFA 200MG METERED DOSE INHALER Budesonide 200 mcg per puff _ _ WHAT IS IN THIS LEAFLET:_ _ a) What Avacort is used for b) How Avacort works c) Before you use Avacort d) How to use Avacort e) While you are using Avacort f) Side effects g) Preparing your Avacort Inhaler h) How to use your inhaler i) Storage and disposal of Avacort j) Product description k) Manufacturer l) Product Registration Holder m) Date of revision WHAT AVACORT IS USED FOR: The name of your medicine is Avacort HFA 200mcg Metered Dose Inhaler (called ‘Avacort’ in this leaflet). Avacort contains a medicine called Budesonide, a glucocorticosteroid, which is a type of steroid. Each puff will contain 200mcg of Budesonide. HOW AVACORT WORKS: Avacort works by reducing and preventing swelling and inflammation of the lungs. BEFORE YOU USE AVACORT WHEN YOU MUST NOT USE IT: Do not take this medicine and tell your doctor if: You are allergic (hypersensitive) to Budesonide or any of the other ingredients of Avacort You have tuberculosis (TB) You have a cold or chest infection You have liver problems BEFORE YOU START TO USE IT: Check with your doctor or pharmacist before taking this medicine : If you are pregnant or planning to become pregnant. If you are breast feeding. If you have liver problems. If you are taking any steroid medicines TAKING OTHER MEDICINES: Tell your doctor about all the medicines you take, including prescription and nonprescription medicines, vitamins, and herbal supplements. Avacort and certain other medicines may interact with each other. Especially tell your doctor if you are taking: - Alcoholic drinks. - CYP3A4 Inhibitors, e.g. Ketoconazole and Itraconazole - Oestrogens and contraceptive steroids - Steroids HOW TO USE AVACORT HOW MUCH TO USE?: The usual dose given by your doctor is one puff in the morning and one puff in the evening. But this may be be increased by your doctor, depending on your conditions. Hence, always Lire le document complet
Page 1 of 3 COMPOSITION: Each metered dose inhaler contains 200 doses of Budesonide 200mcg per dose PRODUCT DESCRIPTION: Avacort HFA 200mcg Metered Dose Inhaler is a one-piece aluminum pressurized containers, containing liquid product under pressure, with no foreign or unpleasant odor, administered via a 50 μl metering valve. It contains 200 doses of 200 micrograms of budesonide per one metered dose. It contains ethanol, polyethylene glycol and Propellant HFA134a. PHARMACOLOGICAL PROPERTIES: PHARMACODYNAMIc PROPERTIES ATC code : R03B A02 Budesonide is a glucocorticosteroid which possesses a high local anti- inflammatory action, with a lower incidence and severity of adverse effects than those seen with oral corticosteroids. PHARMACOKINETIC PROPERTIES ABSORPTION: Following oral inhalation via Avacort HFA 200mcg Metered Dose Inhaler, peak plasma concentrations of budesonide (4.0 nmol/L after a dose of 800 μg) occur within 30 minutes. Maximum plasma concentration and area under the plasma concentration time profile increase linearly with dose, but are slightly (20-30%) higher following repeated doses (3 weeks treatment) than after a single dose. Lung deposition is estimated to 34% ±10% of the metered dose (arithmetic mean ± SD), while 22% will be retained in the mouthpiece and the rest (approximately 45% of the metered dose) will be swallowed. The maximal plasma concentration after inhalation of 1 milligram budesonide is about 3.5 nmol/L and is reached after about 20 minutes. DISTRIBUTION Budesonide has a volume of distribution of approximately 3 L/kg. Plasma protein binding averages 85-90%. METABOLISM: Budesonide undergoes an extensive degree (approximately 90%) of biotransformation on first passage through the liver to metabolites of low glucocorticosteroid activity. The glucocorticosteroid activity of the major metabolites, 6β-hydroxybudesonide and 16α-hydroxyprednisolone, is less than 1% of that of budesonide. The metabolism of budesonide is primarily mediated by CYP3A, a subfamily of cytochrome p450. EXCR Lire le document complet